Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2009
11/18/2009EP1841758B1 Substituted triazole derivatives as oxytocin antagonists
11/18/2009EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors
11/18/2009EP1306372B1 Heterocycle derivatives and drugs
11/18/2009EP1280781B1 5-ht 7 receptor antagonists
11/18/2009EP1218354B1 Quinazoline derivatives and their use as pharmaceuticals
11/18/2009EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009CN101583610A Heterocyclic compounds with CXCR3 antagonist activity
11/18/2009CN101583609A Indoles
11/18/2009CN101583603A Aromatic 1,4-di-carboxylamides and their use
11/18/2009CN101583600A Acetylene derivatives as stearoyl CoA desaturase inhibitors
11/18/2009CN101583365A Triazine derivatives and their therapeutical applications
11/18/2009CN101583276A Substituted 1-(3-pyridinyl)pyrazole-4-yl acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
11/18/2009CN101580523A Novel chemical substance having activity for morphogenesis and growth promotion
11/18/2009CN101580504A Organic compound, benzoxazole derivative, and light-emitting element using the benzoxazole derivative
11/18/2009CN101580502A Method for preparing Rabeprazole sodium
11/18/2009CN101580501A Synthetic method of 3-(substituted dihydro-isoindolone-2-group)-2,6-dioxopiperidine and intermediate thereof
11/18/2009CN101580493A Poly-substituted miazines compound, preparation method and application thereof
11/18/2009CN101580489A Nitrogenous heterocyclic ring compound and preparation method and application thereof
11/18/2009CN100560584C Benzoazolypiperazine derivatives having MGLUR1- and MGLUR5-antagonistic activity
11/18/2009CN100560583C Near infrared fluorescent probe for detecting zinc ion in cell and its synthesis method and use
11/18/2009CN100560582C Piperidinopyrazoles compound and its preparation method and application
11/17/2009US7619096 3-Aminopyrrolidines as inhibitors of monoamine uptake
11/17/2009US7619094 Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus
11/17/2009US7619092 Such as (2R,4S)-1-{N-(3,5-bistrifluoromethylbenzyl)-N-methyl}-aminocarbonyl-2-(4-fluoro-2-methylphenyl)-4-(2-hydroxyethoxy)-piperidine; tachykinin receptor antagonists
11/17/2009US7619091 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052)
11/17/2009US7618987 Acylated piperidine derivatives as melanocortin 4-receptor agonists
11/17/2009US7618985 Isoquinoline derivatives
11/17/2009US7618984 Sulfonamide compound
11/17/2009US7618978 Amides as BACE inhibitors
11/17/2009US7618975 4-arylamino-quinazolines and analogs as activators of caspases and inducers of apoptosis; antiproliferative, anticarcinogenic, antimetabolic agents; tubulin and topoisomerase II inhibitors; fungicides; synergistic administration with other anticarcinogenic agents
11/17/2009US7618970 To treat inflammatory diseases, immune diseases and cancer; N-[(1R,3S)-3-Isopropyl-3-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}carbonyl)cyclopentyl]-3-methoxytetrahydro-2H-pyran-4-amine; side effect reduction; improved long term safety profile; oral administration; half life
11/17/2009CA2521950C Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
11/17/2009CA2470519C Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5
11/17/2009CA2463272C Piperazine derivatives with ccr1 receptor antagonist activity
11/17/2009CA2450801C Drugs that enhance synaptic responses mediated by ampa receptors
11/17/2009CA2441239C Mch antagonists and their use in the treatment of obesity
11/17/2009CA2422925C .delta.1-pyrrolines used as pesticides
11/17/2009CA2417082C New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
11/17/2009CA2382296C Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines
11/17/2009CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
11/17/2009CA2272460C Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
11/17/2009CA2206794C Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs
11/12/2009WO2009137742A1 Process for the preparation of cyano-substituted-nitrogen-containing heteroaryl compounds
11/12/2009WO2009137538A2 Fungicidal substituted azoles
11/12/2009WO2009137429A1 Method of treating cancer using a cmet and axl inhibitor and an erbb inhibitor
11/12/2009WO2009137404A1 Urea compounds as gamma secretase modulators
11/12/2009WO2009137338A1 Pyrazole compounds as ccr1 antagonists
11/12/2009WO2009136995A2 Inhibitors of syk protein kinase
11/12/2009WO2009136850A1 Muscarinic receptor agonits useful in the treatment of pain, alzheimer's disease and schizophrenia
11/12/2009WO2009136191A1 Chemical compounds
11/12/2009WO2009136175A1 Compounds for use in stabilizing p53 mutants
11/12/2009WO2009135944A1 Trisubstituted pyrazoles as acetylcholine receptor modulators
11/12/2009WO2009135842A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/12/2009WO2009135651A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2
11/12/2009WO2009135299A1 3, 4 - substituted piperidine derivatives as renin inhibitors
11/12/2009WO2009102155A3 Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds
11/12/2009WO2009100294A3 Amide derivatives as positive allosteric modulators and methods of use thereof
11/12/2009WO2009071691A3 Oxindole derivatives and the use thereof as a medication
11/12/2009WO2008133344A3 Piperidine derivative and use thereof
11/12/2009WO2007084435A8 Methods for treating hepatitis c
11/12/2009WO2003096987A9 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/12/2009US20090281310 Cinnamide compound
11/12/2009US20090281308 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/12/2009US20090281307 Benzoimidazole compounds
11/12/2009US20090281306 Process for the Preparation of Cgrp Antagonist
11/12/2009US20090281158 Prodrugs of cc-1065 analogs
11/12/2009US20090281147 Method of treating of demyelinating diseases or conditions
11/12/2009US20090281144 Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
11/12/2009US20090281137 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2009US20090281125 Heterocyclic Compounds Useful in Treating Diseases and Conditions
11/12/2009US20090281119 Acid addition salts of n-ethyi-n'-[2-methoxy-4-(5-methyi-4-pryimidin-2-yl)phenyl]urea and uses thereof
11/12/2009US20090281116 Pyrrole derivatives, preparation thereof and therapeutic use thereof
11/12/2009US20090281100 Benzimidazole quinolinones and uses thereof
11/12/2009US20090281099 Substituted pyrazinone derivatives for use as a medicine
11/12/2009US20090281089 Pyridyl inhibitors of hedgehog signalling
11/12/2009US20090281087 Compounds II
11/12/2009US20090281081 Chemokine receptor antagonists and methods of use therefor
11/12/2009US20090281076 Azetidine Derivatives as G-Protein Coupled Receptor (GPR119) Agonists
11/12/2009US20090281072 Diaminopyrimidinecarboxamide Derivative
11/12/2009US20090281060 Heterocyclic derivatives as gpcr receptor agonists
11/12/2009US20090278447 ORGANIC LUMINESCENT DEVICE AND BENZO[k]FLUORANTHENE COMPOUND
11/12/2009US20090278115 Nitrogen-containing heterocyclic derivative and organic electroluminescence element using the same
11/12/2009CA2728893A1 Inhibitors of syk protein kinase
11/12/2009CA2723699A1 Method of treating cancer using a cmet and axl inhibitor and an erbb inhibitor
11/12/2009CA2723679A1 Muscarinic receptor agonists useful in the treatment of pain, alzheimer's disease and schizophrenia
11/12/2009CA2723545A1 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2
11/12/2009CA2722811A1 Pyrazole compounds as ccr1 antagonists
11/12/2009CA2722805A1 Trisubstituted pyrazoles as acetylcholine receptor modulators
11/12/2009CA2722734A1 3,4-substituted piperidine derivatives as renin inhibitors
11/12/2009CA2722606A1 Urea compounds as gamma secretase modulators
11/12/2009CA2721303A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
11/11/2009EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors
11/11/2009EP2116539A1 1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
11/11/2009EP2116538A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
11/11/2009EP2116530A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents
11/11/2009EP2116523A1 Rexinoid compound having alkoxy group
11/11/2009EP2116243A1 Gel composition for treating mycosis
11/11/2009EP2114922A1 Substituted oxindole derivative and its use as a vasopressin receptor modulator
11/11/2009EP2114920A1 Substituted isoquinoline and isoquinolinone derivatives
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 1080